Background: Randomized trials have shown a beneficial effect of anticoagulation with
warfarin to prevent stroke in atrial fibrillation. It is not known whether the same effect will be …

Atrial fibrillation is responsible for more disability than any other cardiac arrhythmia because
of its high incidence and the considerable potential for adverse outcomes. There is …

Purpose: To characterize the efficacy and safety of anticoagulants and antiplatelet agents for
prevention of stroke in patients with atrial fibrillation. Data Sources: Randomized trials …

ContextWarfarin has been shown to be highly efficacious for preventing thromboembolism in
atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is …

OBJECTIVE To evaluate appropriateness of antithrombotic use to prevent stroke in atrial
fibrillation. DESIGN, PATIENTS 344 patients with atrial fibrillation, stratified by age, were …

Atrial fibrillation (AF) is an important risk factor for stroke. According to a pooled analysis of
controlled clinical trials with warfarin, anticoagulation therapy reduces stroke risk by 62 …

Aims Underuse of warfarin for stroke prophylaxis in atrial fibrillation (AF) is extensive and
represents a major problem in clinical practice. To identify factors associated with warfarin …

New anticoagulants add to the therapeutic options for patients with atrial fibrillation, and offer
a number of advantages over warfarin, for both the clinician and patient, including a …

Atrial fibrillation (AF) is a major independent risk factor for stroke. AF is most commonly
associated with nonvalvular cardiovascular disease and is especially frequent among the …

Background: Despite evidence of their benefit and efforts to increase usage, anticoagulation
for stroke prophylaxis in atrial fibrillation (AF) patients remains underutilized. Previous …